Hepion Pharmaceuticals Inc [NASDAQ: HEPA] traded at a low on Wednesday, posting a -58.05 loss after which it closed the day’ session at $0.14.
The results of the trading session contributed to over 35164021 shares changing hands. Over the past one week, the price volatility of Hepion Pharmaceuticals Inc stands at 25.24% while the volatility over the past one month is 15.14%.
The market cap for HEPA stock reached $0.94 million, with 6.96 million shares outstanding and 6.95 million shares in the current float. Compared to the average trading volume of 81.65K shares, HEPA reached a trading volume of 35164021 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Hepion Pharmaceuticals Inc [HEPA]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for HEPA shares is $22.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on HEPA stock is a recommendation set at 3.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
ROTH Capital have made an estimate for Hepion Pharmaceuticals Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on July 20, 2020.
How has HEPA stock performed recently?
Hepion Pharmaceuticals Inc [HEPA] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -71.58. With this latest performance, HEPA shares dropped by -75.89% in over the last four-week period, additionally sinking by -83.93% over the last 6 months – not to mention a drop of -93.66% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for HEPA stock in for the last two-week period is set at 23.13, with the RSI for the last a single of trading hit 17.90, and the three-weeks RSI is set at 26.96 for Hepion Pharmaceuticals Inc [HEPA]. The present Moving Average for the last 50 days of trading for this stock 0.5700, while it was recorded at 0.3607 for the last single week of trading, and 0.8995 for the last 200 days.
Hepion Pharmaceuticals Inc [HEPA]: Deeper insight into the fundamentals
Hepion Pharmaceuticals Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.30 and a Current Ratio set at 1.30.
Insider trade positions for Hepion Pharmaceuticals Inc [HEPA]
There are presently around $7.85%, or 7.85%% of HEPA stock, in the hands of institutional investors.
